Brevan Howard Capital Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37M Buy
46,448
+41,932
+929% +$4.18M 0.04% 281
2025
Q4
$446K Buy
4,516
+980
+28% +$94.8K ﹤0.01% 1173
2025
Q3
$300K Buy
+3,536
New +$279K ﹤0.01% 1567
2025
Q2
Sell
-15,422
Closed -$934K 1920
2025
Q1
$934K Sell
15,422
-37,531
-71% -$2.62M 0.01% 526
2024
Q4
$3.66M Buy
52,953
+16,164
+44% +$1.15M 0.02% 183
2024
Q3
$2.43M Buy
36,789
+14,066
+62% +$897K 0.02% 237
2024
Q2
$1.38M Buy
22,723
+9,091
+67% +$515K 0.01% 288
2024
Q1
$777K Buy
13,632
+7,265
+114% +$436K 0.01% 338
2023
Q4
$400K Buy
+6,367
New +$360K ﹤0.01% 585

Other funds holding INCY

Brevan Howard Capital Management's INCY Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Incyte (INCY) stake by 929% in Q1 2026, buying an estimated $4.18M and bringing the position to 46,448 shares worth $4.37M. The position accounts for 0.04% of the portfolio, ranked #281.

Brevan Howard Capital Management first reported a position in INCY in Q4 2023 and has held it in 9 quarters since. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Brevan Howard Capital Management held 46,448 shares of Incyte worth $4.37M as of Q1 2026.
  • Brevan Howard Capital Management bought 41,932 Incyte shares in Q1 2026, an estimated $4.18M.
  • Incyte made up 0.04% of Brevan Howard Capital Management's portfolio in Q1 2026, its #281 holding.
  • Brevan Howard Capital Management first reported a position in Incyte in Q4 2023 and has held it in 9 quarters since.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.